HomeStocks › CIPLA vs Lupin

CIPLA vs Lupin

A like-for-like valuation of CIPLA (CIPLA) and Lupin (LUPIN), each built from its own filed accounts and set side by side — price against estimated worth, on the same measures.

The short answer

These two cannot be reduced to a single side-by-side number.

We do not publish one fair-value figure for Lupin, because the model that fits it does not collapse to a single per-share value we can stand behind. Compare them instead on the method each is valued by, the multiples they trade on, and what today's price already assumes — all set out below.

Side by side

Every figure below is drawn from each company's own filed statements. Estimated fair value is the per-share figure our engine will stand behind; where a business needs a model that does not reduce to one number, it is shown as “—”.

CIPLACIPLA LupinLUPIN
Current price₹1,351₹2,063
Market cap₹1.09L Cr₹0.94L Cr
Estimated fair value₹1,828
Upside to fair value +35%
P/E32.417.1
P/B3.174.20
Return on equity—%—%
Debt to equity0.000.06
Valued onDiscounted cash flowEstimate withheld — model and market disagree too far

Why compare these two

The closest peer on US-and-India mix.

What each price already assumes

Worked backwards from today's share price: the rate each company must sustain to justify what it costs, against what its own ten-year record supports.

CIPLA
Price implies
0%
sustained growth
History supports
7%
ten-year record
Lupin
Price implies
0%
sustained growth
History supports
17%
ten-year record
Run either valuation in fullFair value, every step of the working, and a PDF report Free during launch →

The full valuation of each

Compare these against others

Same method, same filed accounts — each of these works both companies through to a fair value.

CIPLA vs APOLLO HOSPITALS ENTERPRISELupin vs Dr. Reddy's LaboratoriesCIPLA vs Divi's LaboratoriesLupin vs Sun Pharmaceutical IndustriesCIPLA vs Dr. Reddy's LaboratoriesLupin vs TORRENT PHARMACEUTICALSCIPLA vs Sun Pharmaceutical IndustriesLupin vs ZYDUS LIFESCIENCES

Frequently asked

Is CIPLA or Lupin better value?

We do not publish one fair-value figure for Lupin, because the model that fits it does not collapse to a single per-share value we can stand behind. Compare them instead on the method each is valued by, the multiples they trade on, and what today's price already assumes — all set out below.

How is the CIPLA vs Lupin comparison worked out?

Each company is valued from its own filed financial statements — ten years of results — using the method that fits that business, then set beside the other on price, valuation multiples, return on equity and what today's share price already assumes. It is a like-for-like comparison of the workings, not investment advice.